scispace - formally typeset
K

Kathy Tomkinson

Researcher at Pfizer

Publications -  9
Citations -  1662

Kathy Tomkinson is an academic researcher from Pfizer. The author has contributed to research in topics: Myostatin & Interleukin 1 receptor, type I. The author has an hindex of 4, co-authored 9 publications receiving 1585 citations. Previous affiliations of Kathy Tomkinson include Johns Hopkins University & Johns Hopkins University School of Medicine.

Papers
More filters
Journal ArticleDOI

Induction of cachexia in mice by systemically administered myostatin

TL;DR: It is shown that myostatin circulates in the blood of adult mice in a latent form that can be activated by acid treatment, and may be a useful pharmacologic target in clinical settings such as cachexia, where muscle growth is desired.
Journal ArticleDOI

Temporal associations between interleukin 22 and the extracellular domains of IL-22R and IL-10R2.

TL;DR: A temporal model for the development of a functional IL-22 cytokine-receptor-Fc complex is proposed, based on data studied, which indicates that the IL-10R2(ECD) binds to a surface created by the interaction between IL- 22 and the Il-22R(ECD), and thereby further stabilizes the association ofIL-22 within this cytokine/receptor complex.
Patent

Metalloprotease activation of myostatin, and methods of modulating myostatin activity

TL;DR: In this paper, it was determined that metalloprotease cleavage of a myostatin pro peptide results in activation of a latent inactive myostin to an active form.
Patent

Activacion de miostatina por metaloproteasa, y metodos para modular la actividad de miostatina.

TL;DR: In vitro, un metodo in vitro for disminuir the activación of miostatina was proposed, in which a metaloproteinasa was used to escindir the propeptido de miostata.